Roche buys Genentech
Roche buys Genentech:
"Roche said its Pharma commercial operations in the U.S. will be moved from Nutley, New Jersey, to Genentech's site in South San Francisco, which will become headquarters of the combined company's U.S. commercial operations in pharmaceuticals and operate under the Genentech name."
Don Rumsfeld's baby (Genentech) had wanted $112 a share, Roche counteroffered with a lower bid at 86.50, lots of haggling, then the final offer came in $3 above Roche's initial offer. Genentech (DNA) is still getting a smoking good payoff.
"Roche said its Pharma commercial operations in the U.S. will be moved from Nutley, New Jersey, to Genentech's site in South San Francisco, which will become headquarters of the combined company's U.S. commercial operations in pharmaceuticals and operate under the Genentech name."
Don Rumsfeld's baby (Genentech) had wanted $112 a share, Roche counteroffered with a lower bid at 86.50, lots of haggling, then the final offer came in $3 above Roche's initial offer. Genentech (DNA) is still getting a smoking good payoff.